Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in The Lancet Public Health
- Vol. 3 (1) , e34-e43
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The NHS Cervical Screening ProgrammeInnovAiT: Education and Inspiration for General Practice, 2012
- Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based AnalysisJNCI: Journal of the National Cancer Institute, 2012
- Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission modelBMJ, 2011
- Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United KingdomVaccine, 2010
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyBMJ, 2008
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesVaccine, 2006
- Modeling the Future Burden of Stroke in the NetherlandsStroke, 2005
- Cancer Prevention in Primary Care: Screening for cervical cancerBMJ, 1994
- Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955–1989, their relation to screening and prediction to the year 2000International Journal of Cancer, 1991
- TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMESThe Lancet, 1987